We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ways to Improve Sepsis Care in ICU

By HospiMedica staff writers
Posted on 27 Feb 2004
A research paper outlines "best practice” standards and measures that can improve outcomes and morbidity in sepsis patients in intensive care units (ICUs). More...
The paper was the result of research by doctors and specialists from various healthcare organizations to develop, test, and disseminate quality care measures for sepsis.

By using the following checklist, clinical teams have documented improvements in patient outcomes and morbidity. By using only five of these interventions consistently, the authors of the paper predict that hospitals might prevent 172,000 deaths annually from sepsis.

1) Vancomycin received within 24 hours of ICU admission
2) Mean time to vancomycin initiation
3) Recommended antibiotic received within 24 hours of ICU admission
4) Mean time to antibiotic initiation
5) Blood cultures collected within 24 hours of ICU admission
6) Steroids received within 24 hours of ICU admission
7) Corticotropin stimulation test completed within 24 hours of ICU
admission
8) Activated protein C eligibility assessed within 24 hours of ICU
admission
9) Activated protein C received within 48 hours of ICU admission
10)Vancomycin discontinued within 96 hours of ICU admission
11)Glucose control

Sepsis care is one of the biggest problems in ICUs, departments that are responsible for as much as 30% of all hospital costs, say the researchers. Studies show there are between 500,000 and one million cases of sepsis and severe sepsis annually in U.S. hospitals alone. The annual mortality rate for these patients is 15-30%.

The research paper was prepared by Peter J. Pronovost, M.D., Ph.D., and Sean M. Berenholtz, M.D., MHS, both of Johns Hopkins Medical Institutions (Baltimore, MD, USA), as part of a larger effort by the VHA Inc., a national cooperative of leading not-for-profit healthcare organizations, Johns Hopkins, and the Joint Commission on Accreditation of Healthcare Organizations.




Related Links:
Johns Hopkins

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.